Search
for
Sort by
Research 241–270 of 331
- Delayed granulomatous eruption of the nose associated with ruxolitinib
- Type 2 Diabetes Mellitus and Demodex folliculorum Infestation: A Cross-Sectional Study in Peruvian Patients
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- Application of the waiting time distribution in a nationwide screening of real‐world dermatology drug utilization for aberrant use patterns
- Skin Manifestations of Rheumatological Diseases
- Oral Presentations
- Subject Index
- Pili Torti: A Feature of Numerous Congenital and Acquired Conditions
- Medical Dermatology
- PA11 A rare case of a severe papulopustular dermatosis secondary to a germline <i>EGFR</i> mutation
- The PRIDE (Papulopustules and/or paronychia, Regulatory abnormalities of hair growth, Itching, and Dryness due to Epidermal growth factor receptor inhibitors) syndrome
- Histopathologic features of erythematous papulopustular eruption to epidermal growth factor receptor inhibitors in cancer patients
- Rosacea: I. Etiology, pathogenesis, and subtype classification
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- The management of EGFR inhibitor adverse events: a case series and treatment paradigm
- Cutaneous Drug Eruptions Associated with the Use of New Oncological Drugs
- Chemotherapy-induced iatrogenic injury of skin: New drugs and new concepts
- The incidence and management of cutaneous adverse events of the epidermal growth factor receptor inhibitors
- A distinct cutaneous reaction to sorafenib and a multikinase inhibitor
- Dermoscopic spectrum of rosacea
- Atypical folliculitis caused by Malassezia spp. in immunosuppressed patients
- Cutaneous Adverse Events of Targeted Anticancer Therapy: A Review of Common Clinical Manifestations and Management
- Mitigation of epidermal growth factor receptor inhibitor-induced side effects utilizing melanin and vascular-specific lasers: A case report series
- Pyodermatitis vegetans associated with multiple myeloma
- Dacomitinib-Induced Paronychia Associated With PRIDE Syndrome in a Patient With Non-Small Cell Lung Cancer
- 129 Targeted inhibition of EGFR reduces anti-microbial defense mechanisms at the hair canal
- 176 Hair eruption initiates adverse events of EGFR-targeted cancer therapy
- Mucocutaneous presentations of consultant critical and non-critical cases of admitted COVID-19 patients, outpatients and vaccine-associated dermatoses: a large original study of a general COVID-19 centers from Iran
- 329 Mechanisms of Cutaneous Adverse Events during Targeted Cancer Therapy
- Dermatologic Side Effects of Systemic Targeted Anticancer Therapy